Quest Diagnostics 2007 Annual Report Download - page 6

Download and view the complete annual report

Please find page 6 of the 2007 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 120

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120

and a key enabler of almost everything we
do.฀We฀now฀have฀125,000฀physician฀users฀
of฀our฀Care360 suite of connectivity prod-
ucts. We see tremendous opportunities to
use healthcare IT to make our diagnostic
insights more easily available to doctors,
hospitals and, eventually, patients them-
selves, to improve safety and help drive
better healthcare decisions.
India is an enormous growth opportunity, and
one in which we will be investing over the
next several years. Our offerings in India
include advanced esoteric testing for hospi-
tals, physicians and patients, clinical trials
testing for global pharmaceutical companies,
and risk assessment testing for life insurance
companies.
The Journey Continues…
Our฀strategy,฀based฀on฀Patients,฀Growth฀
and People, has served us well in the past
and it positions us well to take advantage
of opportunities that lie ahead.
Our longer term goals are:
•฀฀To฀grow฀revenues฀profitably฀above฀the฀
industry growth rate;
•฀฀To฀expand฀operating฀margin฀to฀20%฀of฀
revenues;
•฀฀To฀derive฀10%฀of฀consolidated฀revenues฀
internationally฀within฀5฀years;
•฀฀For฀every฀patient฀to฀think฀first฀of฀Quest฀
Diagnostics when it comes to lab test-
ing; and
•฀฀For฀every฀doctor,฀hospital฀administrator,฀
life insurance executive, and pharma-
ceutical research head to think of Quest
Diagnostics as the most trusted source
when it comes to diagnostic testing,
information and services.
We stand at the beginning of a new era
for Quest Diagnostics, in which we have
the opportunity to leverage our assets and
capabilities to become a powerhouse in
healthcare services and information.
I am very proud that, as we go to press,
Quest Diagnostics has been named one of
“America’s฀Most฀Admired฀Companies”฀by฀
Fortune Magazine. We are the only diag-
nostic testing company on this list, which
clearly reinforces our industry leadership
and reputation.
We continue our journey, while writing a
new chapter in the exciting story of Quest
Diagnostics. We can achieve our goals by
flawlessly executing our plan, creating
value for patients, phy sicians, employees
and shareholders, and by leading our
industry forward.
Thank you for your support and continued
confidence.
Take care,
Surya N. Mohapatra, Ph.D.
Chairman,฀President฀and
Chief฀Executive฀Officer
The unique HemoCue testing device platform uses proprietary
cuvette technology to deliver fast, high-quality lab results at the
point of care, using only a few drops of blood from the finger tip.
With an emerging middle
class฀of฀over฀300฀million,฀
India represents a
tremendous growth
opportunity for us.
Our new state-of-the-art
laboratory฀in฀the฀New฀
Delhi฀suburb฀of฀Gurgaon฀
(below) serves doctors,
hospitals, consumers, and
pharmaceutical and life
insurance companies.
Opportunity
Page 4 QU E S T DI A G N O S T I C S 2007 AN N U A L RE P O R T